Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-25-101821
Filing Date
2025-10-23
Accepted
2025-10-23 19:31:21
Documents
2
Period of Report
2025-10-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3031
2 POWER OF ATTORNEY ea026237701ex24_inmed.htm EX-24 8377
  Complete submission text file 0001213900-25-101821.txt   12787
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 189 SYCAMORE DR HAWTHORN WOODS IL 60047
Business Address
Bathery John Steven (Reporting) CIK: 0002093653 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39685 | Film No.: 251414033